Atsena Therapeutics Granted U.S. FDA Fast Track Designation for ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis
UF startup Atsena Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
Evergen Pushing the Boundaries of Tissue Engineering in Regenerative Medicine
Evergen, formerly known as UF startup RTI Surgical, is advancing innovative tissue engineering solutions in regenerative medicine.
LightPath Technologies Expands Orlando Workforce Following $27M Acquisition
UF startup LightPath Technologies is expanding its workforce at its Orlando headquarters following a $27 million acquisition, underscoring its continued growth in next-gen optics and imaging systems.
Lifeward and MYOLYN Expand Partnership To Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use
Lifeward Ltd. and UF startup MYOLYN, Inc., are expanding their exclusive contract to enhance patient access to the MyoCycle FES Cycling Therapy System for home use.
Myosin Therapeutics Closes Second Seed Round To Advance Clinical Trials for Innovative Cancer and Neuroscience Therapies
UF startup Myosin Therapeutics, Inc., a biotechnology company developing novel therapies for cancer and neurological disorders, has closed its second seed funding round, raising over $3 million to supplement significant investment from the National Institutes of Health.
LightPath Technologies Announces Closing of Acquisition of G5 Infrared LLC
UF startup LightPath Technologies, Inc. announced that it has completed the previously announced acquisition of G5 Infrared, LLC, a New Hampshire-based company specializing in infrared optical solutions.
Tech Tuesday: University of Florida Startups Encouraged To Apply for Upcoming GatorPitch Event
In this edition of Tech Tuesday, UF Innovate’s host Bethany Gaffey introduce Melissa Kuchma of UF Innovate, who encourages UF startups to apply to pitch in front of an audience of investors in the Miami area.
Solid Biosciences Reports Positive Initial Clinical Data From Next-Generation Duchenne Gene Therapy Candidate SGT-003
Solid Biosciences Inc., which acquired UF startup AavantiBio, announced positive initial data from the Phase 1/2 INSPIRE DUCHENNE trial evaluating SGT-003, a next-generation gene therapy candidate for treating Duchenne muscular dystrophy.
Evergen Launches AI-Powered Bone Graft Image Processing Software Developed in Partnership With University of Florida
Evergen, a leading CDMO and formerly known as RTI Surgical, a UF startup, announces the launch of new AI-powered image processing software to enhance the analysis of CT bone graft scans.
NovaBone Partners With BEGO for European Launch of Dental Putty With Cartridge Dispenser at IDS 2025
UF startup NovaBone Products has announced a strategic distribution partnership with BEGO, a renowned provider of innovative implantology solutions.